Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Most Common Cancer: Amazing Ways To Fight Back
Most Common Cancer: Amazing Ways To Fight Back 3

In 2025, a lot of people will die from cancer. The top three deadliest cancers are lung, colorectal, and pancreatic. Together, they will cause nearly 40% of all cancer deaths. Fight the most common cancer types with amazing medical tools. Discover vital symptoms and powerful prevention tips for a healthy life.

Lisa Niemi Swayze is working hard to keep Patrick Swayze’s memory alive. He died from pancreatic cancer. This shows how these diseases affect families all over the world.

It’s important to know which most deadly cancer types there are. This knowledge helps doctors find better treatments and improve how patients do.

Key Takeaways

  • The three deadliest cancers are lung, colorectal, and pancreatic cancer.
  • These cancers account for nearly 40% of all cancer deaths expected in 2025.
  • Understanding the worst cancers is key to finding better treatments.
  • Pancreatic cancer is very deadly because it’s often diagnosed late.
  • Lung and colorectal cancers also have high death rates.

The Global Cancer Crisis: Understanding Mortality Rates

The Global Cancer Crisis: Understanding Mortality Rates
Most Common Cancer: Amazing Ways To Fight Back 4

The global cancer crisis is a major issue that affects millions. It shows how serious it is through mortality rates. Cancer is a most common malignancy and has a big impact on health worldwide.

To grasp the cancer crisis, we need to know how it’s measured. Cancer mortality rates show deaths per 100,000 people yearly. This helps compare different places and groups.

How Cancer Deadliness is Measured and Ranked

Cancer deadliness is measured by looking at mortality rates. These rates depend on the cancer type, when it’s found, and treatment success. Work on cholesterol and lipids has helped us understand cancer better.

The ranking of cancer deadliness is based on deaths from certain cancers. Lung cancer is often seen as very deadly because of its high death rate.

The Difference Between Incidence and Mortality

It’s important to know the difference between incidence and mortality rates. Incidence is new cancer cases, while mortality is cancer deaths. A high incidence rate doesn’t always mean a high death rate if cancer is caught early and treated well.

For example, prostate cancer has many cases but fewer deaths because of good screening and treatment. Pancreatic cancer has fewer cases but more deaths because it’s often found late.

Cancer Type

Incidence Rate (per 100,000)

Mortality Rate (per 100,000)

Lung Cancer

55.5

46.2

Breast Cancer

128.4

20.6

Prostate Cancer

106.1

19.4

Cancer Statistics for 2025: A Sobering Outlook

Looking ahead to 2025, the outlook for cancer is grim. We expect to see more cases and deaths. This calls for more awareness and better treatments.

Projected 2 Million New Cancer Cases

In 2025, over 2 million new cancer cases are expected in the United States. This shows how common cancer is. Early detection and treatment are key.

The most common types of cancer include breast, lung, and prostate cancer. These cancers will make up a big part of the numbers.

Men are likely to get prostate cancer, while women face a high risk of breast cancer. The risk varies by area and who you are. This means we need to focus our healthcare efforts.

Expected 618,120 Cancer Deaths in the United States

Unfortunately, cancer deaths are also expected to rise. In 2025, there will be 618,120 deaths from cancer in the United States. This shows how serious the cancer problem is.

We need more research for better treatments. The types of cancer in women, like breast and ovarian, and lung cancer in both men and women, are major causes of death.

Centers like the ProCure Proton Therapy Center are leading the fight against cancer. They offer advanced treatments like proton therapy for cancers like prostate. These new treatments are key to saving lives and improving quality of life for patients.

The Three Deadliest Cancers: Responsible for 40% of Cancer Deaths

The cancer crisis is severe, with some cancers being very aggressive and deadly. Lung, colorectal, and pancreatic cancers are among the worst, causing nearly 40% of all cancer deaths.

Defining “Worst” in Terms of Cancer

When we say some cancers are the “worst,” we mean their high death rates. These cancers affect patients and their families greatly. The term “worst” also considers survival rates and the overall impact.

For example, pancreatic cancer has a very low survival rate. This is because it’s often found late. Lung cancer is also very deadly, due to its aggressive nature and the difficulty in catching it early.

Mortality Rates Compared to Other Cancer Types

Lung, colorectal, and pancreatic cancers have much higher death rates than other cancers. Lung cancer, for instance, is a major cause of cancer deaths worldwide. Its high incidence and aggressive nature contribute to this.

Colorectal cancer is less common but is a big threat. It’s hard to treat when it’s advanced. Pancreatic cancer, with its poor prognosis, completes the list of the deadliest cancers.

Key statistics include:

  • Lung cancer: Leading cause of cancer deaths worldwide
  • Colorectal cancer: Third most common cancer in both men and women
  • Pancreatic cancer: Known for its low survival rate due to late diagnosis

Why These Three Stand Out Among All Cancers

These cancers are unique because of their high incidence, aggressive nature, and treatment challenges. Patrick Swayze’s fight with pancreatic cancer, as shared by his wife Lisa Niemi Swayze, shows the personal toll of these cancers.

Their high death rates urge us to raise awareness, fund research, and push for early detection. This is our best chance to fight these aggressive cancers.

Lung Cancer

Lung cancer is the deadliest cancer, causing the most cancer-related deaths globally. In the United States, it’s expected that about 124,730 people will die from lung cancer. This shows how serious lung cancer is as a health issue.Tontonoz’s research on lipid metabolism has helped us understand lung cancer better. It shows how complex this disease is. Knowing why lung cancer is so deadly, like late diagnosis and aggressive tumors, is key to finding better treatments.Lung cancer is the leading cause of cancer deaths. It’s important to lower smoking rates and improve early detection. By tackling the causes and finding better treatments, we can make lung cancer less deadly.

FAQ

What are the three deadliest cancers?

Lung, colorectal, and pancreatic cancers are the deadliest. They cause a lot of cancer-related deaths worldwide.

How is cancer deadliness measured?

Cancer deadliness is measured by mortality rates. These rates show how many deaths are due to a cancer type. This is different from incidence rates, which count new cases.

What is the difference between incidence and mortality rates?

Incidence rates count new cancer cases. Mortality rates count cancer deaths. A cancer with many new cases might not be as deadly if it’s treatable.

Why are lung, colorectal, and pancreatic cancers considered the deadliest?

These cancers are deadly because of their high mortality rates. This is due to late diagnosis, aggressive tumors, and limited treatments.

What are the projected cancer statistics for 2025 in the United States?

In 2025, the U.S. is expected to see about 2 million new cancer cases and 618,120 cancer deaths.

What is the most common type of cancer death?

Lung cancer is the leading cause of cancer deaths. It accounts for a big part of cancer-related deaths worldwide.

What is the five-year survival rate for lung cancer?

Lung cancer’s five-year survival rate depends on when it’s diagnosed. But overall, it’s lower than many other cancers.

Why is lung cancer so deadly?

Lung cancer is often diagnosed late. Its aggressive nature and limited treatments make it very deadly.

Are there any other prevalent cancers that are considered deadly?

Yes, cancers like colorectal and pancreatic are also deadly. They have high mortality rates and affect public health a lot.

What is the most common malignancy in men and women?

Lung cancer is a top cause of death in both men and women. The most common malignancy can vary between genders.

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from


References

https://www.anaono.com/blogs/dressing-room/7-vitamin-enriched-juicing-recipes-for-cancer-patients?srsltid=AfmBOoqUG5gfIFEwZ2mqNcDPEQuDmntw_kxUdg4ph95SjhSEHmmBoZOi

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91